About Atherotech
Atherotech is a company based in Birmingham (United States) founded in 1994 was acquired by Behrman Capital in January 2011.. Atherotech has raised $999.13 thousand across 2 funding rounds from investors including Pharos Capital Group and Behrman Capital. The company has 335 employees as of December 31, 2015. Atherotech offers products and services including News Platform and Newsletter Service. Atherotech operates in a competitive market with competitors including GEN inCode, SD Biosensor, SpectraWAVE, Lepu Medical Technology and Spectrum Dynamics, among others.
- Headquarter Birmingham, United States
- Employees 335 as on 31 Dec, 2015
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Atherotech, Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$999.13 K (USD)
in 2 rounds
-
Latest Funding Round
$999.13 K (USD), Unspecified
Oct 19, 2009
-
Investors
Pharos Capital Group
& 1 more
-
Employee Count
335
as on Dec 31, 2015
-
Acquired by
Behrman Capital
(Jan 13, 2011)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Atherotech
Atherotech offers a comprehensive portfolio of products and services, including News Platform and Newsletter Service. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Offers articles on medical tech and health innovations
Provides updates on health news and technology
Funding Insights of Atherotech
Atherotech has successfully raised a total of $999.13K across 2 strategic funding rounds. The most recent funding activity was a Unspecified round of $999.13 thousand completed in October 2009. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Unspecified — $999,131
- First Round First Round
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct, 2009 | Amount | Unspecified - Atherotech | Valuation |
investors |
|
| Jun, 2002 | Amount | Unspecified - Atherotech | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Atherotech
Atherotech has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Pharos Capital Group and Behrman Capital. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Healthcare investments are made to improve patient outcomes.
|
Founded Year | Domain | Location | |
|
Private equity firm investing in buyouts of growth companies
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Atherotech
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Atherotech
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Atherotech Comparisons
Competitors of Atherotech
Atherotech operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as GEN inCode, SD Biosensor, SpectraWAVE, Lepu Medical Technology and Spectrum Dynamics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Genetic and clinical data are integrated for precision cardiac medicines.
|
|
| domain | founded_year | HQ Location |
Biosensors for point-of-care diagnostics are developed by SD Biosensor.
|
|
| domain | founded_year | HQ Location |
Photonic imaging diagnostics for cardiovascular disease treatment are provided.
|
|
| domain | founded_year | HQ Location |
Interventional cardiology devices are developed and marketed globally.
|
|
| domain | founded_year | HQ Location |
Cardiac imaging systems are manufactured using advanced molecular technologies.
|
|
| domain | founded_year | HQ Location |
Handheld immunodiagnostic devices for cardiac vascular diseases are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Atherotech
When was Atherotech founded?
Atherotech was founded in 1994 and raised its 1st funding round 8 years after it was founded.
Where is Atherotech located?
Atherotech is headquartered in Birmingham, United States. It is registered at Birmingham, Alabama, United States.
Is Atherotech a funded company?
Atherotech is a funded company, having raised a total of $999.13K across 2 funding rounds to date.
How many employees does Atherotech have?
As of Dec 31, 2015, the latest employee count at Atherotech is 335.
What does Atherotech do?
Atherotech was founded in 1994 in Birmingham, United States, within the healthcare sector. Comprehensive lipid profiles were measured directly through the patented VAP technology, involving density gradient ultracentrifugation. The VAP lipid panel was marketed, assessing nine cardiovascular health markers. Testing services were supplied to physicians, hospitals, clinics, and laboratories across the United States. Operations were ceased in February 2016 due to financial challenges.
Who are the top competitors of Atherotech?
Atherotech's top competitors include GEN inCode, SD Biosensor and SpectraWAVE.
What products or services does Atherotech offer?
Atherotech offers News Platform and Newsletter Service.
Who are Atherotech's investors?
Atherotech has 2 investors. Key investors include Pharos Capital Group, and Behrman Capital.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.